Catalyst Wire Dossier Catalyst Wire Dossier

JANUMET XR

Sitagliptin and metformin hydrochloride · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

19 regulatory and trial events tracked for JANUMET XR, covering 2012-02-02 to 2026-08-11. Get the full timeline:

Most recent: FDA Approved: JANUMET XR — Supplemental Application (Merck Sharp & Dohme LLC)

See pricing